175 related articles for article (PubMed ID: 23740824)
1. Patient perspectives on achieving treat-to-target goals: a critical examination of patient-reported outcomes.
Curtis JR; Shan Y; Harrold L; Zhang J; Greenberg JD; Reed GW
Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1707-12. PubMed ID: 23740824
[TBL] [Abstract][Full Text] [Related]
2. Achieving simplified disease activity index remission in patients with active rheumatoid arthritis is associated with subsequent good functional and structural outcomes in a real-world clinical setting under a treat-to-target strategy.
Hirano F; Yokoyama W; Yamazaki H; Amano K; Kawakami A; Hayashi T; Tamura N; Yasuda S; Dobashi H; Fujii T; Ito S; Kaneko Y; Matsui T; Okuda Y; Saito K; Suzuki F; Yoshimi R; Sakai R; Koike R; Kohsaka H; Miyasaka N; Harigai M;
Mod Rheumatol; 2017 Sep; 27(5):811-819. PubMed ID: 27919205
[TBL] [Abstract][Full Text] [Related]
3. Comparison of physical function in early rheumatoid arthritis patients treated with biologics for 1 year who achieved clinical remission or low disease activity.
Hattori Y; Kida D; Kaneko A
Clin Rheumatol; 2017 Nov; 36(11):2607-2612. PubMed ID: 28823077
[TBL] [Abstract][Full Text] [Related]
4. Determining the acceptable level of physician compliance with a treat-to-target strategy in early rheumatoid arthritis.
Wabe N; Sorich MJ; Wechalekar MD; Cleland LG; McWilliams L; Lee A; Spargo L; Metcalf R; Hall C; Proudman SM; Wiese MD
Int J Rheum Dis; 2017 May; 20(5):576-583. PubMed ID: 26692459
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of treat-to-target strategy in established rheumatoid arthritis: a daily practice prospective cohort study.
de Andrade NPB; da Silva Chakr RM; Xavier RM; Viecceli D; Correa RHB; de Oliveira Filho CM; Brenol CV
Rheumatol Int; 2017 Jun; 37(6):993-997. PubMed ID: 28293776
[TBL] [Abstract][Full Text] [Related]
6. Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis.
Ranganath VK; Maranian P; Elashoff DA; Woodworth T; Khanna D; Hahn T; Sarkisian C; Kremer JM; Furst DE; Paulus HE
Rheumatology (Oxford); 2013 Oct; 52(10):1809-17. PubMed ID: 23813577
[TBL] [Abstract][Full Text] [Related]
7. Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM).
Ramiro S; Landewé RB; van der Heijde D; Sepriano A; FitzGerald O; Ostergaard M; Homik J; Elkayam O; Thorne JC; Larche M; Ferraccioli G; Backhaus M; Boire G; Combe B; Schaeverbeke T; Saraux A; Dougados M; Rossini M; Govoni M; Sinigaglia L; Cantagrel AG; Allaart CF; Barnabe C; Bingham CO; Tak PP; van Schaardenburg D; Hammer HB; Dadashova R; Hutchings E; Paschke J; Maksymowych WP
Ann Rheum Dis; 2020 Apr; 79(4):453-459. PubMed ID: 32094157
[TBL] [Abstract][Full Text] [Related]
8. Measures of arthritis activity associated with patient-reported improvement in rheumatoid arthritis when assessed prospectively versus retrospectively.
Ward MM; Guthrie LC; Alba MI
Arthritis Care Res (Hoboken); 2015 May; 67(6):776-81. PubMed ID: 25370806
[TBL] [Abstract][Full Text] [Related]
9. Determining the Minimally Important Difference in the Clinical Disease Activity Index for Improvement and Worsening in Early Rheumatoid Arthritis Patients.
Curtis JR; Yang S; Chen L; Pope JE; Keystone EC; Haraoui B; Boire G; Thorne JC; Tin D; Hitchon CA; Bingham CO; Bykerk VP
Arthritis Care Res (Hoboken); 2015 Oct; 67(10):1345-53. PubMed ID: 25988705
[TBL] [Abstract][Full Text] [Related]
10. The effect of deep or sustained remission on maintenance of remission after dose reduction or withdrawal of etanercept in patients with rheumatoid arthritis.
Tanaka Y; Smolen JS; Jones H; Szumski A; Marshall L; Emery P
Arthritis Res Ther; 2019 Jul; 21(1):164. PubMed ID: 31277720
[TBL] [Abstract][Full Text] [Related]
11. Management of rheumatoid arthritis in clinical practice using treat-to-target strategy: Where do we stand in the multi-ethnic Malaysia population?
Tan BE; Lim AL; Kan SL; Lim CH; Ng YF; Tng SLC; Hassin NS; Chandran L; Hamid NA; Lee YYL
Rheumatol Int; 2017 Jun; 37(6):905-913. PubMed ID: 28389855
[TBL] [Abstract][Full Text] [Related]
12. Time to remission in swollen joints is far faster than patient reported outcomes in rheumatoid arthritis: results from the Ontario Best Practices Research Initiative (OBRI).
Pope JE; Rampakakis E; Movahedi M; Cesta A; Sampalis JS; Bombardier C;
Rheumatology (Oxford); 2021 Feb; 60(2):717-727. PubMed ID: 32789456
[TBL] [Abstract][Full Text] [Related]
13. Joint damage progression in patients with rheumatoid arthritis in clinical remission: do biologics perform better than synthetic antirheumatic drugs?
Ciubotariu E; Gabay C; Finckh A;
J Rheumatol; 2014 Aug; 41(8):1576-82. PubMed ID: 25028383
[TBL] [Abstract][Full Text] [Related]
14. Biologics initiation in moderate versus severe rheumatoid arthritis: real-world experience from a Canadian registry.
Guo N; Li X; Movahedi M; Cesta A; Bombardier C
Clin Exp Rheumatol; 2024 May; 42(5):1067-1074. PubMed ID: 38372710
[TBL] [Abstract][Full Text] [Related]
15. Adding ultrasound to treat-to-target shows no benefit in achieving clinical remission nor in slowing radiographic progression in rheumatoid arthritis: results from a multicenter prospective cohort.
Sepriano A; Ramiro S; Landewé R; van der Heijde D; Ohrndorf S; FitzGerald O; Backhaus M; Larché M; Homik J; Saraux A; Hammer HB; Terslev L; Østergaard M; Burmester G; Combe B; Dougados M; Hitchon C; Boire G; Lambert RG; Dadashova R; Paschke J; Hutchings EJ; Maksymowych WP
Clin Rheumatol; 2024 Jun; 43(6):1833-1844. PubMed ID: 38684600
[TBL] [Abstract][Full Text] [Related]
16. Rapid improvement of Clinical Disease Activity Index (CDAI) at 3 months predicts a preferable CDAI outcome at 1 year in active rheumatoid arthritis patients treated with tocilizumab: results from an observational investigation of daily clinical practice.
Kawashiri SY; Nishino A; Suzuki T; Nakashima Y; Horai Y; Ueki Y; Aramaki T; Fujikawa K; Nakashima M; Okada A; Migita K; Mizokami A; Matsuoka N; Mine M; Sakito S; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Aoyagi K; Eguchi K; Kawakami A
Clin Exp Rheumatol; 2016; 34(5):808-812. PubMed ID: 27384149
[TBL] [Abstract][Full Text] [Related]
17. Sustained Remission Improves Physical Function in Patients with Established Rheumatoid Arthritis, and Should Be a Treatment Goal: A Prospective Observational Cohort Study from Southern Sweden.
Einarsson JT; Geborek P; Saxne T; Kristensen LE; Kapetanovic MC
J Rheumatol; 2016 Jun; 43(6):1017-23. PubMed ID: 27036384
[TBL] [Abstract][Full Text] [Related]
18. Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patients.
Jawaheer D; Messing S; Reed G; Ranganath VK; Kremer JM; Louie JS; Khanna D; Greenberg JD; Furst DE
Arthritis Care Res (Hoboken); 2012 Dec; 64(12):1811-8. PubMed ID: 22730408
[TBL] [Abstract][Full Text] [Related]
19. Cluster-Randomized Trial of a Behavioral Intervention to Incorporate a Treat-to-Target Approach to Care of US Patients With Rheumatoid Arthritis.
Harrold LR; Reed GW; John A; Barr CJ; Soe K; Magner R; Saunders KC; Ruderman EM; Haselkorn T; Greenberg JD; Gibofsky A; Harrington JT; Kremer JM
Arthritis Care Res (Hoboken); 2018 Mar; 70(3):379-387. PubMed ID: 28544704
[TBL] [Abstract][Full Text] [Related]
20. A Prospective Evaluation of the Effects of Prevalent Depressive Symptoms on Disease Activity in Rheumatoid Arthritis Patients Treated With Biologic Response Modifiers.
Rathbun AM; Harrold LR; Reed GW
Clin Ther; 2016 Jul; 38(7):1759-1772.e3. PubMed ID: 27368116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
